Lexeo Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LXEO and other ETFs, options, and stocks.About LXEO
Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company, which engages in the development of therapies for hereditary and acquired diseases. The firm focuses on the medication of genetically defined cardiovascular diseases and sub-group of Alzheimer’s disease.
CEOR. Nolan Townsend
CEOR. Nolan Townsend
Employees72
Employees72
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2017
Founded2017
Employees72
Employees72
LXEO Key Statistics
Market cap785.34M
Market cap785.34M
Price-Earnings ratio-3.69
Price-Earnings ratio-3.69
Dividend yield—
Dividend yield—
Average volume1.06M
Average volume1.06M
High today$10.79
High today$10.79
Low today$9.86
Low today$9.86
Open price$10.05
Open price$10.05
Volume1.32M
Volume1.32M
52 Week high$10.79
52 Week high$10.79
52 Week low$1.45
52 Week low$1.45
Stock Snapshot
Lexeo Therapeutics(LXEO) stock is priced at $10.76, giving the company a market capitalization of 785.34M. It carries a P/E multiple of -3.69.
On 2025-12-19, Lexeo Therapeutics(LXEO) stock moved within a range of $9.86 to $10.79. With shares now at $10.76, the stock is trading +9.1% above its intraday low and -0.3% below the session's peak.
Trading volume for Lexeo Therapeutics(LXEO) stock has reached 1.32M, versus its average volume of 1.06M.
The stock's 52-week range extends from a low of $1.45 to a high of $10.79.
The stock's 52-week range extends from a low of $1.45 to a high of $10.79.
Analyst ratings
100%
of 11 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own LXEO. This list is generated using Robinhood data, and it’s not a recommendation.